期刊文献+

过氧化物酶体增殖物激活受体α在肝脏代谢性疾病和肝毒性中的研究进展 被引量:4

下载PDF
导出
摘要 过氧化物酶体增殖物激活受体α(PPARα)隶属于核受体家族,在机体生长发育、新陈代谢以及病理生理过程中发挥着重要的作用[1]。PPARα的靶基因多参与组织中脂质和糖的代谢,尤其在肝脏、肌肉、心脏等高耗氧的组织中,因此,PPARα常作为治疗肝脏代谢性疾病药物的作用靶点。但是近几年的研究发现,PPARα与胆汁淤积、非酒精性脂肪性肝病(NA FLD)、糖尿病等的发生发展密切相关,
出处 《中西医结合肝病杂志》 CAS 2016年第2期124-127,共4页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
基金 国家自然科学基金(No.81273582 No.81302848) 浙江省公益性项目(No.2015C37110) 浙江省大学生新苗人才计划(No.2015R405055)
  • 相关文献

参考文献41

  • 1Feige JN, Gelman L, Michalik L, et aL From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions [ J]. Prog Lipid Res, 2006, 45(2) : 120-159.
  • 2Hummasti STontonoz P. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adi- pogenesis [J]. Mol Endocrinol, 2006, 20(6) : 1261-1275.
  • 3Pawak M, Lefebvre PStaels B. Molecular mechanism of PPARalpha ac- tion and its impact on lipid metabolism, inflamrrmtion and fibrosis in non- alcoholic fatty liver disease [J]. J Hepatol, 2015, 62(3) : 720-733.
  • 4Issemann IGreen S. Activation of a member of the steroid hormone re- ceptor superfamily by peroxisome proliferators [ J]. Nature, 1990, 347(6294) : 645-650.
  • 5Auboeuf D, Rieusset J, Fajas L, et al. Tissue distribution and quanti- fication of the expression of mRNAs of peroxisome proliferator-activa- ted receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients [ J]. Diabetes, 1997, 46 (8) : 1319-1327.
  • 6Adeghate E, Adem A, Hasan MY, et al. Medicinal Chemistry and Actions of Dual and Pan PPAR Modulators [ J]. Open Med Chem J, 2011, 5(Suppl 2) : 93-98.
  • 7Hiukka A, Maranghi M, Matikainen N, et al. PPARalpha: an emer- ging therapeutic target in diabetic microvascular damage [J]. Nat Rev Endocrinol, 2010, 6(8): 454-463.
  • 8Lefebvre P, Chinetti G, Fruchart JC, et al. Sorting out the roles ofPPAR alpha in energy metabolism and vascular homeostasis [ J ]. J Clin Invest, 2006, 116(3) : 571-580.
  • 9Matsubara T, Tanaka N, Patterson AD, et al. Lithocholic acid dis- rupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice [J]. Hepatology, 2011,53(4) : 1282-1293.
  • 10Cheng XKlaassen CD. Critical tale of PPAR-alpha in perfluorooctano- ic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers [J]. Toxieol Sci, 2008, 106 (1) : 37-45.

同被引文献65

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部